Literature DB >> 10760814

Assessment of the interaction of human complement regulatory proteins with group A Streptococcus. Identification of a high-affinity group A Streptococcus binding site in FHL-1.

D Pérez-Caballero1, S Albertí, F Vivanco, P Sánchez-Corral, S Rodríguez de Córdoba.   

Abstract

Group A Streptococcus (GAS), the most frequent bacterial cause of suppurative infections in humans, expresses on the cell surface M proteins with capacity to bind factor H, FHL-1 and C4b binding protein (C4BP). This has been interpreted as a mechanism developed by this pathogen to decrease phagocytosis by macrophages and polymorphonuclear cells. We report the analysis of the capacity to bind factor H, FHL-1 and C4BP of 69 clinical isolates from 19 different serotypes. We show that strains binding complement regulators (30/69) belong to specific M serotypes. Of these, M18 strains are relatively frequent and interact with all three complement regulators simultaneously. However, the most virulent M1 and M3 strains did not bind complement regulators in our assays. The relevance of the interaction between complement regulators and S. pyogenes was analyzed using different approaches with the conclusion that under physiological conditions only FHL-1 and C4BP bind to streptococci. We show that FHL-1 presents a higher binding affinity for S. pyogenes than factor H because it carries a hydrophobic, high-affinity, GAS binding site in addition to the heparin binding site in SCR7. Using synthetic peptides we provide evidence that the high-affinity GAS binding site in FHL-1 involves the hydrophobic tail (Ser-Phe-Thr-Leu) that distinguishes FHL-1 from factor H.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760814     DOI: 10.1002/(SICI)1521-4141(200004)30:4<1243::AID-IMMU1243>3.0.CO;2-D

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes.

Authors:  B A Fernie-King; D J Seilly; C Willers; R Würzner; A Davies; P J Lachmann
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 2.  Subversion of the innate immune response by micro-organisms.

Authors:  B Fernie-King; D J Seilly; A Davies; P J Lachmann
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

3.  Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation.

Authors:  David G Wooster; Ravi Maruvada; Anna M Blom; Nemani V Prasadarao
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

4.  A Role of Epithelial Cells and Virulence Factors in Biofilm Formation by Streptococcus pyogenes In Vitro.

Authors:  Feiruz Alamiri; Yashuan Chao; Maria Baumgarten; Kristian Riesbeck; Anders P Hakansson
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

5.  Disruption of the alternative pathway convertase occurs at the staphylococcal surface via the acquisition of factor H by Staphylococcus aureus.

Authors:  Julia A Sharp; Kenji M Cunnion
Journal:  Mol Immunol       Date:  2010-12-15       Impact factor: 4.407

6.  Identification and functional characterization of complement regulator-acquiring surface protein 1 of the Lyme disease spirochetes Borrelia afzelii and Borrelia garinii.

Authors:  Reinhard Wallich; Joseph Pattathu; Veronique Kitiratschky; Christiane Brenner; Peter F Zipfel; Volker Brade; Markus M Simon; Peter Kraiczy
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  Impact of the SpeB protease on binding of the complement regulatory proteins factor H and factor H-like protein 1 by Streptococcus pyogenes.

Authors:  Lin Wei; Vinod Pandiripally; Eugene Gregory; Micaya Clymer; David Cue
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

8.  Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1.

Authors:  Vinod Pandiripally; Eugene Gregory; David Cue
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

9.  Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi.

Authors:  P Kraiczy; C Skerka; V Brade; P F Zipfel
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

10.  Bordetella pertussis acquires resistance to complement-mediated killing in vivo.

Authors:  Elizabeth J Pishko; David J Betting; Christina S Hutter; Eric T Harvill
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.